HIGHLIGHTS
- who: September et al. from the (iCONM), Japan Xiamen University, China have published the research work: Applications of phase change materials in smart drug delivery for cancer treatment, in the Journal: (JOURNAL)
- how: In vivo experiment results showed that the LCTL could target the tumor and remain at the tumor site for more than 24 h. After irradiation with 808 nm NIR the in_vivo results showed that photothermal could totally ablate the tumor.
- future: Eventually this paper also discusses the potential application of PCMs in clinical tumor treatments and the future directions of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.